Regulation	NN	regulation NN PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-b1-driven	JJ	transforming-growth-factor-b1-driven JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
by	IN	by IN PennPOS
galectin-3	NN	galectin-3 NN PennPOS
.	.	. . NUPOS

RATIONALE	NN	rationale NN PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
chronic	JJ	chronic JJ PennPOS
dysregulated	VBN	dysregulate VBN PennPOS
response	NN	response NN PennPOS
to	TO	to p-acp NUPOS
alveolar	JJ	alveolar JJ PennPOS
epithelial	JJ	epithelial JJ PennPOS
injury	NN	injury NN PennPOS
with	IN	with pp NUPOS
differentiation	NN	differentiation NN PennPOS
of	IN	of pp-f NUPOS
epithelial	JJ	epithelial JJ PennPOS
cells	NNS	cell NNS PennPOS
and	CC	and cc NUPOS
fibroblasts	NNS	fibroblast NNS PennPOS
into	IN	into pp NUPOS
matrix-secreting	JJ	matrix-secreting JJ PennPOS
myofibroblasts	NNS	myofibroblast NNS PennPOS
resulting	VBG	result VBG PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
scaring	VBG	scare vvg NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
prognosis	NN	prognosis NN PennPOS
is	VBZ	be vbz NUPOS
poor	JJ	poor JJ PennPOS
and	CC	and cc NUPOS
there	EX	there pc-acp NUPOS
are	VBP	be vbb NUPOS
no	DT	no dx NUPOS
effective	JJ	effective JJ PennPOS
therapies	NNS	therapy NNS PennPOS
or	CC	or cc NUPOS
reliable	JJ	reliable JJ PennPOS
biomarkers	NNS	biomarker NNS PennPOS
.	.	. . NUPOS

Galectin-3	NN	Galectin-3 NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
b-galactoside	NN	b-galactoside NN PennPOS
binding	NN	binding NN PennPOS
lectin	NN	lectin NN PennPOS
that	WDT	that WDT PennPOS
is	VBZ	be vbz NUPOS
highly	RB	high av-j NUPOS
expressed	VBN	express VBN PennPOS
in	IN	in IN PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
tissue	NN	tissue NN PennPOS
of	IN	of pp-f NUPOS
diverse	JJ	diverse JJ PennPOS
etiologies	NNS	etiology NNS PennPOS
.	.	. . NUPOS

OBJECTIVES	NNS	objective NNS PennPOS
:	:	: : NUPOS
To	TO	to p-acp NUPOS
examine	VB	examine VBP PennPOS
the	DT	the dt NUPOS
role	NN	role NN PennPOS
of	IN	of pp-f NUPOS
galectin-3	NN	galectin-3 NN PennPOS
in	IN	in IN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

METHODS	NNS	method NNS PennPOS
:	:	: : NUPOS
We	PRP	we pns12 NUPOS
used	VBD	use VBD PennPOS
genetic	JJ	genetic JJ PennPOS
deletion	NN	deletion NN PennPOS
and	CC	and cc NUPOS
pharmacologic	JJ	pharmacologic JJ PennPOS
inhibition	NN	inhibition NN PennPOS
in	IN	in IN PennPOS
well-characterized	JJ	well-characterized JJ PennPOS
murine	JJ	murine JJ PennPOS
models	NNS	model NNS PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Further	JJ	further JJ PennPOS
mechanistic	JJ	mechanistic JJ PennPOS
studies	NNS	study NNS PennPOS
were	VBD	be vbd NUPOS
performed	VBN	perform VBN PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
and	CC	and cc NUPOS
on	IN	on IN PennPOS
samples	NNS	sample NNS PennPOS
from	IN	from pp NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

MEASUREMENTS	NNS	measurement NNS PennPOS
AND	CC	and cc NUPOS
MAIN	NNS	main NN PennPOS
RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
Transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
b	NN	b NN PennPOS
and	CC	and cc NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
was	VBD	be vbd NUPOS
dramatically	RB	dramatic av-j NUPOS
reduced	VBN	reduce VBN PennPOS
in	IN	in IN PennPOS
mice	NNS	mouse n2 NUPOS
deficient	JJ	deficient JJ PennPOS
in	IN	in IN PennPOS
galectin-3	NN	galectin-3 NN PennPOS
,	,	, , NUPOS
manifest	JJ	manifest JJ PennPOS
by	IN	by IN PennPOS
reduced	VBN	reduce VBN PennPOS
TGF-b1-induced	JJ	tgf-b1-induced JJ PennPOS
EMT	NN	emt NN PennPOS
and	CC	and cc NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
activation	NN	activation NN PennPOS
and	CC	and cc NUPOS
collagen	NN	collagen NN PennPOS
production	NN	production NN PennPOS
.	.	. . NUPOS

Galectin-3	NN	Galectin-3 NN PennPOS
reduced	VBD	reduce VBD PennPOS
phosphorylation	NN	phosphorylation NN PennPOS
and	CC	and cc NUPOS
nuclear	JJ	nuclear JJ PennPOS
translocation	NN	translocation NN PennPOS
of	IN	of pp-f NUPOS
b-catenin	NN	b-catenin NN PennPOS
but	CC	but cc-acp NUPOS
had	VBD	have vhd NUPOS
no	DT	no dx NUPOS
effect	NN	effect NN PennPOS
on	IN	on IN PennPOS
Smad2/3	NN	Smad2/3 NN PennPOS
phosphorylation	NN	phosphorylation NN PennPOS
.	.	. . NUPOS

A	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
inhibitor	NN	inhibitor NN PennPOS
of	IN	of pp-f NUPOS
galectin-3	NN	galectin-3 NN PennPOS
,	,	, , NUPOS
TD139	NN	TD139 NN PennPOS
,	,	, , NUPOS
blocked	VBD	block VBD PennPOS
TGF-b-induced	JJ	tgf-b-induced JJ PennPOS
b-catenin	NN	b-catenin NN PennPOS
activation	NN	activation NN PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
and	CC	and cc NUPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
and	CC	and cc NUPOS
attenuated	VBD	attenuate VBD PennPOS
the	DT	the dt NUPOS
late-stage	JJ	late-stage JJ PennPOS
progression	NN	progression NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
after	IN	after c-acp NUPOS
bleomycin	NN	bleomycin NN PennPOS
.	.	. . NUPOS

There	EX	there pc-acp NUPOS
was	VBD	be vbd NUPOS
increased	VBN	increase VBN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
galectin-3	NN	galectin-3 NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
fluid	NN	fluid NN PennPOS
and	CC	and cc NUPOS
serum	NN	serum NN PennPOS
from	IN	from pp NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
stable	JJ	stable JJ PennPOS
IPF	NN	IPF NN PennPOS
compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
nonspecific	JJ	nonspecific JJ PennPOS
interstitial	JJ	interstitial JJ PennPOS
pneumonitis	NN	pneumonitis NN PennPOS
and	CC	and cc NUPOS
controls	NNS	control NNS PennPOS
,	,	, , NUPOS
which	WDT	which r-crq NUPOS
rose	VBD	rise VBD PennPOS
sharply	RB	sharp av-j NUPOS
during	IN	during pp NUPOS
an	DT	a dt NUPOS
acute	JJ	acute JJ PennPOS
exacerbation	NN	exacerbation NN PennPOS
suggesting	VBG	suggest VBG PennPOS
that	IN	that cst NUPOS
galectin-3	NN	galectin-3 NN PennPOS
may	MD	may vmb NUPOS
be	VB	be vbi NUPOS
a	DT	a dt NUPOS
marker	NN	marker NN PennPOS
of	IN	of pp-f NUPOS
active	JJ	active JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
and	CC	and cc NUPOS
that	IN	that cst NUPOS
strategies	NNS	strategy NNS PennPOS
that	WDT	that WDT PennPOS
block	VBP	block VBP PennPOS
galectin-3	NN	galectin-3 NN PennPOS
may	MD	may vmb NUPOS
be	VB	be vbi NUPOS
effective	JJ	effective JJ PennPOS
in	IN	in IN PennPOS
treating	VBG	treat VBG PennPOS
acute	JJ	acute JJ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
exacerbations	NNS	exacerbation NNS PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

CONCLUSIONS	NNS	conclusion NNS PennPOS
:	:	: : NUPOS
This	DT	this d NUPOS
study	NN	study NN PennPOS
identifies	VBZ	identify VBZ PennPOS
galectin-3	NN	galectin-3 NN PennPOS
as	IN	as c-acp NUPOS
an	DT	a dt NUPOS
important	JJ	important JJ PennPOS
regulator	NN	regulator NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
provides	VBZ	provide VBZ PennPOS
a	DT	a dt NUPOS
proof	NN	proof NN PennPOS
of	IN	of pp-f NUPOS
principle	NN	principle NN PennPOS
for	IN	for c-acp NUPOS
galectin-3	NN	galectin-3 NN PennPOS
inhibition	NN	inhibition NN PennPOS
as	IN	as c-acp NUPOS
a	DT	a dt NUPOS
potential	JJ	potential JJ PennPOS
novel	JJ	novel JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
strategy	NN	strategy NN PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

